Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Sell
40
RLYB Quote, Financials, Valuation and Earnings
Last price:
$0.46
Seasonality move
:
-6.94%
Day range:
$0.43 - $0.50
52-week range:
$0.22 - $1.54
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
23.88x
P/B ratio:
0.35x
Volume:
1.4M
Avg. volume:
5.7M
1-year change:
-67.29%
Market cap:
$18.9M
Revenue:
$636K
EPS (TTM):
-$1.09
Earnings Data
Next earnings date for RLYB
Aug 08
2025
Most recent earnings per share
-$0.21
Beat by $0.08
(May 8/2025)
Consensus Estimate
-$0.29
(May 8/2025)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
RLYB Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 09/30/2025 | Q3 | -- | -- | -- | -$0.19 | -- |
| 08/08/2025 | Q2 | -- | -- | -- | -$0.25 | -- |
| 05/08/2025 | Q1 | -- | $212K | -$0.21 | -$0.29 | $0.08 |
| 03/13/2025 | Q4 | $75K | $38K | -$0.25 | -$0.30 | $0.05 |
| 11/07/2024 | Q3 | -- | $299K | -$0.26 | -$0.34 | $0.08 |
| 08/08/2024 | Q2 | -- | $299K | -$0.37 | -$0.36 | -$0.01 |
| 05/09/2024 | Q1 | -- | -- | -$0.47 | -$0.46 | -$0.01 |
| 03/12/2024 | Q4 | -- | -- | -$0.49 | -$0.43 | -$0.06 |
| 11/09/2023 | Q3 | -- | -- | -$0.45 | -$0.50 | $0.05 |
| 08/08/2023 | Q2 | -- | -- | -$0.46 | -$0.47 | $0.01 |
| 05/09/2023 | Q1 | -- | -- | -$0.43 | -- | -- |
| 03/06/2023 | Q4 | -- | -- | -$0.46 | -- | -- |
| 11/07/2022 | Q3 | -- | -- | -$0.60 | -- | -- |
| 08/08/2022 | Q2 | -- | -- | -$0.57 | -- | -- |
| 05/10/2022 | Q1 | -- | -- | -$0.48 | -- | -- |
| 03/15/2022 | Q4 | -- | -- | -$0.42 | -- | -- |
| 11/10/2021 | Q3 | -- | -- | -$0.37 | -- | -- |
| 09/09/2021 | Q2 | -- | -- | -$0.36 | -- | -- |
| 03/31/2021 | Q1 | -- | -- | -$0.60 | -- | -- |
| 12/31/2020 | Q4 | -- | -- | -$0.47 | -- | -- |
| 09/30/2020 | Q3 | -- | -- | -$0.32 | -- | -- |
| 06/30/2020 | Q2 | -- | -- | -$0.22 | -- | -- |
| 03/31/2020 | Q1 | -- | -- | -$0.17 | -- | -- |
Rallybio Earnings Questions
-
How Much did Rallybio Generate in Revenue Last Quarter?
Rallybio reported $212K worth of top line sales in its most recent quarter.
-
Did Rallybio Beat Earnings Last Quarter?
Rallybio announced earnings per share of -$0.21 which represents a beat of analyst forecast a -$0.29 per share.
-
Is Rallybio Profitable?
Rallybio reported -- that represents -- per share over the last quarter.
-
What is the Analyst Consensus for Rallybio EPS Next Year?
Rallybio's earnings are forecast to decrease from -$1.33 per share to -$1.45 per share next year representing a decrease of -36.47%.
-
When is Rallybio's Earnings Date?
Rallybio's next earnings date is August 8, 2025.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will FCX Benefit From Tariffs?
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Can Levi Stock Double?
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Stock Ideas
Buy
71
Is NVDA Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 59x
Buy
51
Is MSFT Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 43x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 35x
Alerts
Buy
72
SBET alert for Jul 18
SharpLink Gaming [SBET] is down 2.6% over the past day.
Buy
68
MCRI alert for Jul 18
Monarch Casino & Resort [MCRI] is up 19.81% over the past day.
Sell
41
NEGG alert for Jul 18
Newegg Commerce [NEGG] is up 17.85% over the past day.
